Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: Modulation of astrocytoma invasive potential

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 1, 1996, Pages 88-96

  Matsuzawa, Kazuhito ^a   Fukuyama, Kouzou ^a   Hubbard, Sherri Lynn ^a   Dirks, Peter B ^a   Rutka, James T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Astrocytoma; Invasion; Metalloproteinases; TIMP 1; Transfection

Indexed keywords

COMPLEMENTARY DNA; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; ASTROCYTOMA; CANCER GROWTH; CANCER INVASION; CASE REPORT; CELL DEGENERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; METASTASIS POTENTIAL; MOLECULAR CLONING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030051305     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199601000-00009     Document Type: Article

References (51)

1. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-68
2. Waxman J, Wasan H. The architecture of cancer: The tissue metalloproteinases and their inhibitors. British Med J 1992;305:1306-7
3. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986;46:1-7
4. Apodaca G, Rutka JT, Bouhana K, et al. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990;50:2322-29
5. Khokha R, Denhardt DT. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invasion and Metastasis 1989;9:391-405
6. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-36
7. Halaka AN, Bunning RAD, Bird CC, Gibson M, Reynolds JJ. Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. J Neurosurg 1983;59:461-66
8. Rucklidge GJ, Lund-Johansen M, Milne G, Bjerkvig R. Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum free culture. BBRC 1990; 172:544-50
9. Rutka JT, Hubbard SL, Fukuyama K, et al. Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: Correlation with astrocytoma cell invasiveness. Int J Oncol 1995;6:877-84
10. Nakagawa T, Kubota T, Kabuto M, et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 by human brain tumors. J Neurosurg 1994;81:69-77
11. Rutka JT, Giblin JR. Dougherty DV, et al Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 1987;75:92-103
12. Carmichael DF, Sommer A, Thompson RC, et al. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci 1986;83:2407-11
13. Stinski MF, Thomsen DR, Stenberg RM, Goldstein L. Organization and expression of the immediate early genes of human cytomegalovirus. J Virol 1983;46:1-14
14. Repesh LA. A new in vitro assay for quantitating tumor cell invasion. Invasion and Metastasis 1989;9:192-208
15. Rutka JT, Rosenblum ML. Stern R. Isolation and partial purification of transforming growth factors from human malignant gliomas. J Neurosurg 1989;7:375-83
16. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202
17. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells: II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 1986;261:2814-18
18. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8
19. Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 1993;53:4493-98
20. Laemmli UK. Cleavage of stractual proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 1970;227:680-85
21. Rutka JT, Apodaca G, Stern R, Rosenblum, ML. The extracellular matrix of the central and peripheral nervous systems: Structure and function. J Neurosurg 1988;69:155-70
22. Rutka JT, Myatt CA, Giblin JR, Davis RL, Rosenblum ML. Distribution of extracellular matrix oroteins in orimarv human brain tumours: An immunohistochemical analysis. Can J Neurol Sci 1987;14:25-30
23. Ogilvie SJ, Hailey JA, Juacaba SR Lee ECG, Tarin D. Collagenase secretion by human breast neoplasms: A clinicopathologic investigation J Nat Cancer Inst 1985;74:19-28
24. Levy AT, Cioce V, Sobel ME, et al. Increased expression of the Mr 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res 1991;51:439-44
25. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WC. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 1991;4: 239-46
26. Pyke C, Ralfkiaer E, Huhtala P. Hurslainen T, Dano K, Tryggvason K. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992;52.1336-41
27. Stearns ME, Wang M. Type IV collagenase (Mr 72,000) expression in human prostate: Benign and malignant tissue. Cancer Res 1993;53:878-83
28. Pyke C, Ralfkiaer E, Tryggvason K, Dano K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-64
29. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Cancer 1993;67:1126-31
30. Davies B, Waxman J, Wasan H, et al. Levels of matrix metalloprotemases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993,53:5365-69
31. Thorgeirsson UP, Liotta LA, Kalebic T, et al. Effect of natural protease inhibitor and a chemoattractant on tumor cell invasion in vitro. J Natl Cancer Inst 1982;69:1049-57
32. Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 1986;47:478-98
33. Schultz RM, Silberman S, Persky B, Bajkowski AS. Carmichael DF. Inhibition by human recombinant tissue inhibitor of metallo-proteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 1988;48:5539-45
34. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990;82.589-95
35. Khokha R, Waterhouse P, Yagel S, et al. Antisense RNA-induced reduction in murine TIMP levels confers tumorigenicity on Swiss 3T3 cells. Science 1989;243:947-50
36. Smith DR, Hardman JM, Earle KM. Metastasizing neuroectodermal tumors of the central nervous system. J Neurosurg 1969;31.50-58
37. Schuster H, Jellinger K, Gund A. Extracranial metastases of anaplastic cerebral glioma. Acta Neurochir 1976;35:247-59
38. Khokha R, Zimmer MJ, Wilson SM, Chambers AF. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992;10: 365-70
39. Montgomery AMP, Mueller BM, Reisfield RA, Taylor SM, DeClerk YA. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 1994;54:5467-73
40. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990;248:1408-10
41. Bertaux B, Hornebeck W, Eisen AZ, Duberret I. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Investigative Dermatology 1991;97:679-85
42. Denhardt DT, Khokha R, Yagel S, Overall CM, Parhar RS. Oncogenic consequences of down-modulating TIMP expression in 3T3 cells with antisense RNA. In: Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, eds. Matrix Supplement 1. New York, Gustav Fischer Verlag, 1992
43. Southgate KM, Davies M, Booth RFG, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 1992;288.93-99
44. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation J Cell Physiol 1993;157:351-58
45. Takigawa M, Nishida Y, Suzuki F, Kishi J. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 1990; 171:1264-71
46. Hayakawa T, Yamashita K, Tanzawa K, Ekuko U, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. Fed Eur Biochem Soc 1992;298:29-32
47. Stetler-Stevenson WG, Bersch N, Golde DW. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. Fed Eur Biochem Soc 1992;296:231-34
48. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J Biol Chem 1989;264:17374-78
49. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72-and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13070-75
50. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler Stevenson WC. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991;83:775-79
51. Testa JE, Quigley JP. Reversal of misfortune: TIMP-2 inhibits tumor cell invasion. J Natl Cancer Inst 1991;83:740-2